Results 1 to 10 of about 314,176 (271)

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19 [PDF]

open access: yesJournal of Central Nervous System Disease, 2022
Introduction Post-COVID-19 syndrome affects approximately 10-25% of people suffering from COVID-19 infection, irrespective of initial COVID-19 severity. Fatigue is one of the major symptoms, occurring in 30-90% of people with post-COVID-19 syndrome. This
Lara Diem MD   +12 more
doaj   +2 more sources

The Relationship between Post-COVID Syndrome and the Burden of Comorbidities Assessed Using the Charlson Comorbidity Index [PDF]

open access: yesMedicina, 2023
Introduction: The post-COVID-19 syndrome is a clinical entity characterized by the manifestation of signs and symptoms that develop after the acute phase of COVID-19, which persist for a duration of more than 12 weeks and are not explained by any ...
Lorenzo Falsetti   +12 more
doaj   +3 more sources

The Relationship between Paresthesia and the Presence of Cardiac Dysautonomia in Patients with Post-COVID-19 Syndrome: A Preliminary Observational Study [PDF]

open access: yesBrain Sciences, 2023
Introduction: Post-Coronavirus disease 2019 (Post-COVID-19) syndrome has neurological symptoms related to the dysfunction of the autonomous nerve system.
Erislandis López-Galán   +4 more
doaj   +3 more sources

Ultrasound-Guided Infiltrative Treatment Associated with Early Rehabilitation in Adhesive Capsulitis Developed in Post-COVID-19 Syndrome [PDF]

open access: yesMedicina, 2023
Background and Objectives: Post-COVID-19 syndrome is commonly used to describe signs and symptoms that continue or develop after acute COVID-19 for more than 12 weeks. The study aimed to evaluate a treatment strategy in patients with adhesive capsulitis (
Danilo Donati   +11 more
doaj   +3 more sources

Post-COVID-19 Syndrome as Described by Patients: A Qualitative Study. [PDF]

open access: yesHealthcare (Basel)
Background/Objectives: Growing interest in post-viral conditions following COVID-19 infection has led researchers and clinicians to develop several definitions of post-COVID-19 syndrome.
Fonda F   +9 more
europepmc   +3 more sources

Post-COVID-19 Syndrome and Related Dysautonomia: Reduced Quality of Life, Increased Anxiety and Manifestation of Depressive Symptoms: Evidence from Greece

open access: yesActa Medica Lituanica, 2023
Background: Post-COVID-19 syndrome affects a significant number of SARS-CoV-2 infected individuals, even in asymptomatic cases causing several neurological and neuropsychiatric symptoms and signs.
Petros Galanis   +8 more
doaj   +3 more sources

Post-traumatic stress disorder and post COVID 19 syndrome

open access: yesEuropean Psychiatry, 2023
Introduction Patients hospitalized in the case of COVID19 have had to face a complex and potentially very stressful situation. In this context a screening program for psychological distress in patients with COVID19 is necessary. Objectives To screen for
N. Halouani   +6 more
doaj   +1 more source

Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study. [PDF]

open access: yes, 2022
INTRODUCTION Post-COVID-19 syndrome affects approximately 10-25% of people after a COVID-19 infection, irrespective of initial COVID-19 severity. The aim of this project was to assess the clinical characteristics, course, and prognosis of post-COVID ...
Bassetti, Claudio   +11 more
core   +1 more source

Post‐Coronavirus disease syndrome (post‐COVID‐19) syndrome: A case report

open access: yesClinical Case Reports, 2022
Post‐COVID syndrome, a cluster of symptoms that develops or persists even after the recovery from COVID‐19 or viral clearance, can have multi‐system manifestations.
Rukshar Thapa   +6 more
doaj   +1 more source

Post-COVID-19 syndrome risk factors and further use of health services in East England

open access: yesPLOS Global Public Health, 2022
Post-COVID syndrome, defined as symptoms persisting for more than twelve weeks after the diagnosis of COVID-19, has been recognised as a new clinical entity in the context of SARS-CoV-2 infection.
Maciej Debski   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy